Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Published
Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.
Full ArticlePublished
Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.
Full ArticleNew Analysis Suggests , Long-Term Effectiveness , for Wegovy Users .
NBC reports that patients taking
Novo Nordisk's..
Latest Weight-Loss Drug , Faces Shortages .
The United States Food and Drug Administration
(FDA) says that high demand..